Several studies identified significantly higher serum soluble CD30 (sCD30, released by CD30+ cells) levels in AD patients than in non-AD controls (93–107), and sCD30 levels were positively correlated with AD disease severity (93, 95, 98, 103, 107). The gene discussed is TNFRSF8; the disease is Alzheimer disease.